Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://oisizvzv535047.jts-blog.com/37729152/semaglutide-a-potential-solution-for-metabolic-disorders